Trial Profile
Phase III trial of milciclib in patients with malignant thyoma
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 22 Sep 2015
Price :
$35
*
At a glance
- Drugs Milciclib (Primary)
- Indications Malignant thymoma
- Focus Therapeutic Use
- 22 Sep 2015 New trial record